白细胞介素-7诱导潜伏性1型人类免疫缺陷病毒的表达，对T细胞表型影响极小。
Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype.
作者信息
Scripture-Adams Deirdre D, Brooks David G, Korin Yael D, Zack Jerome A
机构信息
Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California at Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
出版信息
J Virol. 2002 Dec;76(24):13077-82. doi: 10.1128/jvi.76.24.13077-13082.2002.
Abstract
Latent human immunodeficiency virus type 1 (HIV-1) persists even in patients treated with antiretroviral therapy. New treatment strategies are therefore needed to eradicate this latent viral reservoir without reducing immune cell function. We characterize the interleukin-7 (IL-7)-induced stimulation of primary human T cells and thymocytes and demonstrate, using the SCID-hu model, that IL-7 induces substantial expression of latent HIV while having minimal effects on the cell phenotype. Thus, IL-7 is a viable candidate to activate expression of latent HIV and may facilitate immune clearance of latently infected cells.
摘要
即使在接受抗逆转录病毒疗法治疗的患者中，潜伏的1型人类免疫缺陷病毒（HIV-1）仍会持续存在。因此，需要新的治疗策略来根除这种潜伏的病毒库，同时又不降低免疫细胞功能。我们对白细胞介素-7（IL-7）诱导的原代人T细胞和胸腺细胞刺激进行了表征，并使用SCID-hu模型证明，IL-7可诱导潜伏HIV的大量表达，而对细胞表型的影响最小。因此，IL-7是激活潜伏HIV表达的可行候选物，可能有助于对潜伏感染细胞的免疫清除。
相似文献
1
Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype.白细胞介素-7诱导潜伏性1型人类免疫缺陷病毒的表达，对T细胞表型影响极小。
J Virol. 2002 Dec;76(24):13077-82. doi: 10.1128/jvi.76.24.13077-13082.2002.
2
Effects of prostratin on T-cell activation and human immunodeficiency virus latency.苔藓抑素对T细胞活化及人类免疫缺陷病毒潜伏的影响。
J Virol. 2002 Aug;76(16):8118-23. doi: 10.1128/jvi.76.16.8118-8123.2002.
3
Molecular characterization, reactivation, and depletion of latent HIV.潜伏性HIV的分子特征、重新激活及清除
Immunity. 2003 Sep;19(3):413-23. doi: 10.1016/s1074-7613(03)00236-x.
4
HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.在抑制性口服联合抗逆转录病毒疗法期间，人源化NSG小鼠模型中的HIV复制与潜伏
J Virol. 2018 Mar 14;92(7). doi: 10.1128/JVI.02118-17. Print 2018 Apr 1.
5
Effect of latent human immunodeficiency virus infection on cell surface phenotype.潜伏性人类免疫缺陷病毒感染对细胞表面表型的影响。
J Virol. 2002 Feb;76(4):1673-81. doi: 10.1128/jvi.76.4.1673-1681.2002.
6
Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T Cells.伏立诺他使人类免疫缺陷病毒（HIV）复制型潜伏库易受 CD8 T 细胞清除。
EBioMedicine. 2017 Sep;23:52-58. doi: 10.1016/j.ebiom.2017.07.019. Epub 2017 Jul 29.
7
The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.Tat抑制剂双脱氢皮质抑素A可防止HIV-1从潜伏状态重新激活。
mBio. 2015 Jul 7;6(4):e00465. doi: 10.1128/mBio.00465-15.
8
Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal.小分子 BAF 抑制剂；HIV-1 潜伏逆转中极有前途的化合物家族。
EBioMedicine. 2015 Nov 27;3:108-121. doi: 10.1016/j.ebiom.2015.11.047. eCollection 2016 Jan.
9
Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART.接受高效抗逆转录病毒治疗（HAART）的HIV患者静息CD4 + T细胞库补充的限制因素
PLoS Pathog. 2007 Aug 31;3(8):e122. doi: 10.1371/journal.ppat.0030122.
10
Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.长期接受抗逆转录病毒治疗的儿科患者中，1型人类免疫缺陷病毒潜伏库中野生型病毒的持续存在及缺乏时间结构。
J Virol. 2002 Sep;76(18):9481-92. doi: 10.1128/jvi.76.18.9481-9492.2002.
引用本文的文献
1
Heat shock protein 90 is a chaperone regulator of HIV-1 latency.热休克蛋白90是HIV-1潜伏状态的一种伴侣调节因子。
PLoS Pathog. 2025 Apr 1;21(4):e1012524. doi: 10.1371/journal.ppat.1012524. eCollection 2025 Apr.
2
Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells.确定蛋白激酶C调节剂类HIV潜伏逆转剂对自然杀伤细胞的作用。
Pathog Immun. 2024 Apr 24;9(1):108-137. doi: 10.20411/pai.v9i1.673. eCollection 2024.
3
Immunomodulation with IL-7 and IL-15 in HIV-1 infection.HIV-1感染中白细胞介素-7和白细胞介素-15的免疫调节作用
J Virus Erad. 2023 Sep 5;9(3):100347. doi: 10.1016/j.jve.2023.100347. eCollection 2023 Sep.
4
IL-15 and N-803 for HIV Cure Approaches.用于治愈艾滋病方法的白细胞介素-15和N-803
Viruses. 2023 Sep 12;15(9):1912. doi: 10.3390/v15091912.
5
New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention.治疗性操纵 HIV-1 转录和潜伏期的新概念：潜伏期逆转与潜伏期预防。
Viruses. 2023 Jul 31;15(8):1677. doi: 10.3390/v15081677.
6
Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal.蛋白激酶 C 调节剂诱导的分泌因子不会间接导致 HIV 潜伏逆转。
Virology. 2023 Apr;581:8-14. doi: 10.1016/j.virol.2023.02.009. Epub 2023 Feb 16.
7
Cell-to-cell transmission of HIV-1 from provirus-activated cells to resting naïve and memory human primary CD4 T cells is highly efficient and requires CD4 and F-actin but not chemokine receptors.HIV-1 从原病毒激活的细胞到静止的初始和记忆性人源原代 CD4 T 细胞的细胞间传播效率极高，需要 CD4 和 F-肌动蛋白，但不需要趋化因子受体。
J Med Virol. 2022 Nov;94(11):5434-5450. doi: 10.1002/jmv.28005. Epub 2022 Jul 23.
8
The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcription.基于 ingenol 的蛋白激酶 C 激动剂 GSK445A 是一种强效诱导 HIV 和 SIV RNA 转录的物质。
PLoS Pathog. 2022 Jan 18;18(1):e1010245. doi: 10.1371/journal.ppat.1010245. eCollection 2022 Jan.
9
Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.潜伏的人类免疫缺陷病毒 1 型前病毒的低诱导率是治愈的主要障碍。
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):13-21. doi: 10.1093/infdis/jiaa649.
10
Latency Reversal 2.0: Giving the Immune System a Seat at the Table.潜伏期逆转 2.0：让免疫系统参与其中。
Curr HIV/AIDS Rep. 2021 Apr;18(2):117-127. doi: 10.1007/s11904-020-00540-z. Epub 2021 Jan 12.
本文引用的文献
1
Modalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytes.白细胞介素-7诱导静止T淋巴细胞中人类免疫缺陷病毒易感性的方式。
J Virol. 2002 Sep;76(18):9103-11. doi: 10.1128/jvi.76.18.9103-9111.2002.
2
Effects of exogenous interleukin-7 on human thymus function.外源性白细胞介素-7对人胸腺功能的影响。
Blood. 2002 Apr 15;99(8):2851-8. doi: 10.1182/blood.v99.8.2851.
3
Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals.血浆中的白细胞介素-7与CD4 T细胞耗竭相关，且可能与1型人类免疫缺陷病毒阳性个体中合胞体诱导变体的出现有关。
J Virol. 2001 Nov;75(21):10319-25. doi: 10.1128/JVI.75.21.10319-10325.2001.
4
IL-7 differentially regulates cell cycle progression and HIV-1-based vector infection in neonatal and adult CD4+ T cells.白细胞介素-7对新生儿和成人CD4 + T细胞的细胞周期进程及基于HIV-1的载体感染具有不同的调节作用。
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9277-82. doi: 10.1073/pnas.161272698. Epub 2001 Jul 24.
5
IL-7 is critical for homeostatic proliferation and survival of naive T cells.白细胞介素-7对于初始T细胞的稳态增殖和存活至关重要。
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8732-7. doi: 10.1073/pnas.161126098. Epub 2001 Jul 10.
6
A potential role for interleukin-7 in T-cell homeostasis.白细胞介素-7在T细胞稳态中的潜在作用。
Blood. 2001 May 15;97(10):2983-90. doi: 10.1182/blood.v97.10.2983.
7
Infection of the CD45RA+ (naive) subset of peripheral CD8+ lymphocytes by human immunodeficiency virus type 1 in vivo.1型人类免疫缺陷病毒在体内对外周CD8+淋巴细胞的CD45RA+（初始）亚群的感染。
J Virol. 2001 May;75(9):4091-102. doi: 10.1128/JVI.75.9.4091-4102.2001.
8
Generation of HIV latency during thymopoiesis.胸腺生成过程中HIV潜伏期的产生。
Nat Med. 2001 Apr;7(4):459-64. doi: 10.1038/86531.
9
Interleukin-7 restores immunity in athymic T-cell-depleted hosts.白细胞介素-7可恢复无胸腺T细胞耗竭宿主的免疫力。
Blood. 2001 Mar 15;97(6):1525-33. doi: 10.1182/blood.v97.6.1525.
10
IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation.白细胞介素-7可增强骨髓移植后胸腺依赖性和非胸腺依赖性T细胞的再生。
Blood. 2001 Mar 1;97(5):1491-7. doi: 10.1182/blood.v97.5.1491.
Zotero 插件